# QUVIVIQ

NDC: 80491-7825
Generic name: Daridorexant
Labeler / Manufacturer: Idorsia Pharmaceuticals Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20220407

FDA application: NDA214985

## Active ingredients

- DARIDOREXANT: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"80491-7825"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=80491-7825
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a2d1503-b816-40c9-9fac-7e03c5a3bcef